Open AccessThe Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
Author(s) -
David Walling,
Howard Hassman,
Lourdes Anta,
Lourdes Ochoa,
I. Ayani,
Javier Martínez,
I. Gutierro
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s332026
Subject(s) - risperidone , bioavailability , pharmacology , medicine , schizophrenia (object oriented programming) , psychiatry
This open-label, one-sequence study evaluated the steady-state comparative bioavailability of risperidone in situ microimplants (ISM ® ) and oral risperidone in patients stabilized on oral risperidone treatment.